Eucalyptus

Eucalyptus is a leading Australian healthtech company that operates a vertically integrated telehealth platform. Founded in 2019, the company specializes in creating demographic-focused digital clinics that connect patients with practitioners and pharmacists for consultations, e-prescriptions, and medication delivery. By addressing inefficiencies in traditional healthcare, Eucalyptus provides high-touch, patient-centered care across various specialized brands including Pilot, Juniper, Software, Kin, and Compound. In June 2026, the company was acquired by the NYSE-listed health and wellness giant Hims & Hers Health in a transaction valued at approximately US$1.15 billion, marking a significant milestone in its growth and international expansion. The company maintains a strong focus on clinical standards, being the first telehealth provider in Australia to receive accreditation from the Australian Council on Healthcare Standards (ACHS).

Good health to last a lifetime.

• Acquired by Hims & Hers Health in 2026 for US$1.15 billion
• First telehealth company in Australia accredited by the Australian Council on Healthcare Standards (ACHS)
• Maintains ISO-27001 cybersecurity standards
• Facilitated over one million practitioner consultations
• Expanded operations into the UK, Germany, Japan, and Canada

Sources

• Official Website
• Forbes Australia
• Crunchbase